These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33945927)

  • 41. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.
    Yao JK; Dougherty GG; Reddy RD; Keshavan MS; Montrose DM; Matson WR; Rozen S; Krishnan RR; McEvoy J; Kaddurah-Daouk R
    Mol Psychiatry; 2010 Sep; 15(9):938-53. PubMed ID: 19401681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder.
    Chou YH; Hsieh WC; Chen LC; Lirng JF; Wang SJ
    J Affect Disord; 2016 Feb; 191():29-35. PubMed ID: 26630394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients.
    Mouri A; Ikeda M; Koseki T; Iwata N; Nabeshima T
    Neurosci Lett; 2016 Mar; 617():22-6. PubMed ID: 26845564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression.
    Ho PS; Ho KK; Huang WS; Yen CH; Shih MC; Shen LH; Ma KH; Huang SY
    Psychiatry Res; 2013 Jun; 212(3):216-22. PubMed ID: 23149035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.
    Réus GZ; Jansen K; Titus S; Carvalho AF; Gabbay V; Quevedo J
    J Psychiatr Res; 2015 Sep; 68():316-28. PubMed ID: 26028548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus.
    Okamoto N; Hoshikawa T; Honma Y; Chibaatar E; Ikenouchi A; Harada M; Yoshimura R
    Eur Arch Psychiatry Clin Neurosci; 2024 Oct; 274(7):1697-1707. PubMed ID: 37991535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonin transporter availability may moderate the association between perceiving stress and depressive tendencies - A SPECT with 5-HTTLPR genotyping study.
    Lin SH; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Yang YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():24-9. PubMed ID: 25816791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder.
    Badawy AA; Dawood S; Bano S
    World J Psychiatry; 2023 Apr; 13(4):141-148. PubMed ID: 37123095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
    Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stress and Kynurenine-Inflammation Pathway in Major Depressive Disorder.
    Mingoti MED; Bertollo AG; de Oliveira T; Ignácio ZM
    Adv Exp Med Biol; 2023; 1411():163-190. PubMed ID: 36949310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
    Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
    Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Antidepressant Potential of NONHSAG045500 in Regulating Serotonin Transporter in Major Depressive Disorder.
    Liu S; Zhou B; Wang L; Hu H; Yao C; Cai Z; Cui X
    Med Sci Monit; 2018 Jun; 24():4465-4473. PubMed ID: 29955033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response.
    Ho MF; Zhang C; Zhang L; Wei L; Zhou Y; Moon I; Geske JR; Choi DS; Biernacka J; Frye M; Wen Z; Karpyak VM; Li H; Weinshilboum R
    Mol Psychiatry; 2021 Jul; 26(7):3122-3133. PubMed ID: 32753686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment.
    Ye D; Xu H; Xia H; Zhang C; Tang Q; Bi F
    J Exp Clin Cancer Res; 2021 May; 40(1):173. PubMed ID: 34006301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
    Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex Differences in Branched-chain Amino Acid and Tryptophan Metabolism and Pathogenesis of Youth-onset Type 2 Diabetes.
    Hernandez N; Lokhnygina Y; Ramaker ME; Ilkayeva O; Muehlbauer MJ; Crawford ML; Grant RP; Hsia DS; Jain N; Bain JR; Armstrong S; Newgard CB; Freemark M; Gumus Balikcioglu P
    J Clin Endocrinol Metab; 2024 Mar; 109(4):e1345-e1358. PubMed ID: 38066593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes.
    Claes S; Myint AM; Domschke K; Del-Favero J; Entrich K; Engelborghs S; De Deyn P; Mueller N; Baune B; Rothermundt M
    Psychiatry Res; 2011 Aug; 188(3):355-60. PubMed ID: 21492941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.